HI
Vyome Holdings, Inc. (HIND)
NASDAQ·Healthcare·Biotechnology
$2.20
+0.00%
Mkt Cap $15.01M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+581.8%
Consensus $15.00 vs current $2.20
NASDAQ·Healthcare·Biotechnology
$2.20
+0.00%
Mkt Cap $15.01M
No recent rating data.
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+581.8%
Consensus $15.00 vs current $2.20